Publikationen von 0000-0003-0542-7989
(ORCID: 0000-0003-0542-7989)

Szeimies, R.-M., Morton, M. A., Basset‐Seguin, N., Calzavara‐Pinton, P., Gilaberte, Y., Hædersdal, M., Hofbauer, G. F. L. , Hunger, R. E., Karrer, S., Piaserico, S., Ulrich, C., Wennberg, A.-M. und Braathen, L. R. (2020) European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses. Journal of the European Academy of Dermatology and Venereology 34 (1), S. 17-29.

Szeimies, R.-M., Morton, M. A., Basset‐Seguin, N., Calzavara‐Pinton, P., Gilaberte, Y., Hædersdal, M., Hofbauer, G. F. L. , Hunger, R. E., Karrer, S., Piaserico, S., Ulrich, C., Wennberg, A.-M. und Braathen, L. R. (2019) European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas. Journal of the European Academy of Dermatology and Venereology 33 (12), S. 2225-2238.

Morton, Colin, Szeimies, Rolf-Markus, Sidoroff, Alexis, Wennberg, Ann-Marie, Basset-Seguin, Nicole, Calzavara-Pinton, Piergiacomo, Gilaberte, Yolanda , Hofbauer, Günther , Hunger, Robert, Karrer, Sigrid, Lehmann, Percy, Piaserico, Stefano, Ulrich, Claas und Braathen, Lasse (2015) European Dermatology Forum Guidelines on topical photodynamic therapy. European Journal of Dermatology 25 (4), S. 296-311. Volltext nicht vorhanden.

Dirschka, T., Radny, P., Dominicus, R., Mensing, H., Brüning, H., Jenne, L., Karl, L., Sebastian, M., Oster-Schmidt, C., Klövekorn, W., Reinhold, U., Tanner, M., Gröne, D., Deichmann, M., Simon, M., Hübinger, F., Hofbauer, G. , Krähn-Senftleben, G., Borrosch, F., Reich, K., Berking, C., Wolf, P., Lehmann, P., Moers-Carpi, M., Hönigsmann, H., Wernicke-Panten, K., Helwig, C., Foguet, M., Schmitz, B., Lübbert, H. und Szeimies, R.-M. (2011) Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. British Journal of Dermatology 166 (1), S. 137-146. Volltext nicht vorhanden.